Home › Research › Prevention trials
Personalized Multi-Domain Digital Platform for Dementia Prevention
Seyed-Mohammad Fereshtehnejad, Karim Keshavjee, Abbas Zavar. Studies in health technology and informatics, 2025-02-18
Topic: Brain imaging, connectivity and assessment
The Personalized Multi-Domain Digital Platform for Dementia Prevention (PM(DP)*2) is a conceptualized evidence-based initiative designed to reduce dementia burden through tailored interventions. By collecting and analyzing multidimensional data on modifiable risk factors, including lifestyle, cardiovascular health, and environmental exposures, the platform creates individualized risk profiles and recommends personalized prevention strategies. Machine learning models and generative AI enhance the platform's ability to offer dynamic, evidence driven recommendations.
Key findings
- The Personalized Multi-Domain Digital Platform for Dementia Prevention (PM(DP)*2) is a conceptualized evidence-based initiative designed to reduce dementia burden through tailored interventions.
- By collecting and analyzing multidimensional data on modifiable risk factors, including lifestyle, cardiovascular health, and environmental exposures, the platform creates individualized risk profiles and recommends personalized prevention strategies.
- Machine learning models and generative AI enhance the platform's ability to offer dynamic, evidence driven recommendations.
New to this subject? Start with our plain-English guide: Prevention →
Study details
- Evidence strengthLow
How this study scored 43/100
Published in a peer-reviewed journal. Scored zero for study design, sample size, effect reported, studied in people and randomised / blinded because the record does not state it. We have no data on journal's citation record, times cited, citations per year, impact for its field and year, cited by studies here, still being cited, senior author's track record, institution's track record, multi-centre collaboration and free to read, so those were left out: it earned 24 of the 56 points we could judge it on, which is 43 out of 100.
| Component | Points | Why |
|---|---|---|
| Journal tier | 7 / 10 | Tier 3 — peer-reviewed journal (Studies in health technology and informatics) |
| Journal's citation record | — / 4 | No journal record from OpenAlex — left out of this score |
| Study design | 0 / 12 | No study design recorded — scores zero, not guessed (not stated in the record — scored 0) |
| Strength of evidence | 1 / 5 | Rated “low” in our summary |
| Peer-review validation | 10 / 10 | Peer-reviewed. Published as an article in a named peer-reviewed journal. |
| How recent | 4 / 5 | 2025 — within 3 year(s) of the newest study here |
| Sample size | 0 / 4 | Participant count not stated — scores zero (not stated in the record — scored 0) |
| Effect reported | 0 / 3 | No effect size reported — scores zero (not stated in the record — scored 0) |
| Studied in people | 0 / 3 | Not stated whether this was studied in people — scores zero (not stated in the record — scored 0) |
| Randomised / blinded | 0 / 2 | No randomisation or blinding stated — scores zero (not stated in the record — scored 0) |
| Times cited | — / 7 | No citation count (not found in OpenAlex) — left out of this score |
| Citations per year | — / 5 | No citation count or no year — left out of this score |
| Impact for its field and year | — / 6 | No field-weighted citation impact (OpenAlex has none yet) — left out of this score |
| Cited by studies here | — / 6 | Not yet checked against this library's citation graph — left out of this score |
| Still being cited | — / 4 | No yearly citation counts — left out of this score |
| Senior author's track record | — / 4 | Senior author's record not available — left out of this score |
| Institution's track record | — / 3 | No institution listed in OpenAlex — left out of this score |
| Multi-centre collaboration | — / 3 | Institutions not listed — left out of this score |
| Indexed in PubMed | 2 / 2 | Indexed in PubMed (PMID 39968562) |
| Free to read | — / 2 | Access not recorded — left out of this score |
| Points | 24 / 56 | Scored on 10 of 20 parts. We have no data for the rest, so they are left out: 24 of the 56 points we could judge it on is 43 out of 100. |
| Total | 43 / 100 | — |
What each of these 20 components measures, and what this score is not →
Read the original
Free copy unknown: no free-copy check has an answer for this record yet. That does not mean it is paywalled.
Cite this study APA, Vancouver, BibTeX · download .bib or .ris
Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. Check the citation against the original before you use it.
APA 7th
Fereshtehnejad, S.-M., Keshavjee, K., & Zavar, A. (2025). Personalized Multi-Domain Digital Platform for Dementia Prevention. Studies in health technology and informatics. https://doi.org/10.3233/shti250030
Vancouver
Fereshtehnejad S.-M, Keshavjee K, Zavar A. Personalized Multi-Domain Digital Platform for Dementia Prevention. Studies in health technology and informatics. 2025. doi:10.3233/shti250030. PMID: 39968562.
BibTeX
@article{fereshtehnejad2025-39968562,
author = {Fereshtehnejad, Seyed-Mohammad and Keshavjee, Karim and Zavar, Abbas},
title = {{Personalized Multi-Domain Digital Platform for Dementia Prevention}},
journal = {Studies in health technology and informatics},
year = {2025},
doi = {10.3233/shti250030},
pmid = {39968562},
url = {https://doi.org/10.3233/shti250030}
}
Related studies in Prevention trials
Also tagged “convolutional”
205 studies in the library carry the topic tag “convolutional”; these are this study's neighbours in a fixed, alphabetical-by-hash tour of them, not the closest in content. All 205 tagged studies.